Year archive

MEMPHASYS LIMITED. — 2024 filings

All 100 regulatory filings released by MEMPHASYS LIMITED. (MEM) in 2024, sourced directly from the official regulator.

100 Filings

2024 Period

2024 filings (100)

Filing	Released	Lang
Top Up Offer Completion 1 page 216.6KB Capital/Financing Update	2024-12-22	English
Bovine Study commences to assess RoXsta antioxidant system 2 pages 262.6KB Regulatory Filings	2024-12-19	English
Application for quotation of securities - MEM 6 pages 18.7KB Share Issue/Capital Change	2024-12-19	English
Notification regarding unquoted securities - MEM 7 pages 21.2KB Capital/Financing Update	2024-12-19	English
Felix Clinical Registration Study completed, expanding mkt 2 pages 233.5KB Regulatory Filings	2024-12-17	English
Letter of Intent with Heranova for Felix System Distribution 3 pages 275.2KB Capital/Financing Update	2024-12-11	English
RoXsta System's Potential in Cattle Breeding being Explored 2 pages 245.1KB Regulatory Filings	2024-12-04	English
Order for Felix System to Evaluate Suitability in UAE 3 pages 249.3KB Regulatory Filings	2024-12-04	English
Notification of cessation of securities - MEM 4 pages 14.8KB Regulatory Filings	2024-12-04	English
Second Supplementary Prospectus 4 pages 140.6KB Capital/Financing Update	2024-11-28	English
Extension of convertible note 2 pages 183.0KB Capital/Financing Update	2024-11-27	English
Initial Director's Interest Notice - LE 2 pages 187.8KB Director's Dealing	2024-11-26	English
Final Director's Interest Notice - RC 2 pages 168.8KB Director's Dealing	2024-11-26	English
Address to Shareholders 2 pages 238.3KB AGM Information	2024-11-21	English
Results of Meeting 2 pages 340.4KB Declaration of Voting Results & Voting Rights Announcements	2024-11-21	English
Chair Appointment/Resignation 2 pages 189.5KB Board/Management Information	2024-11-20	English
Felix Clinical Trial Reaches 95% Completion 2 pages 199.2KB Capital/Financing Update	2024-11-17	English
RoXsta System Secures Provisional Patent Approval 2 pages 221.3KB Regulatory Filings	2024-11-14	English
Application for quotation of securities - MEM 6 pages 18.6KB Share Issue/Capital Change	2024-11-07	English
Notification regarding unquoted securities - MEM 6 pages 19.8KB Share Issue/Capital Change	2024-11-07	English
Completion of Placement and SPP offer 2 pages 202.5KB Capital/Financing Update	2024-11-04	English
Application for quotation of securities - MEM 6 pages 18.5KB Capital/Financing Update	2024-11-04	English
Notification regarding unquoted securities - MEM 6 pages 20.3KB Share Issue/Capital Change	2024-11-04	English
Alteration to Notice of Meeting (AGM venue) 16 pages 654.4KB AGM Information	2024-10-30	English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 418.9KB Interim / Quarterly Report Q1 2025	2024-10-29	English
MEM Investor Presentation 35 pages 5.0MB Investor Presentation	2024-10-24	English
Results of Meeting 2 pages 56.4KB Declaration of Voting Results & Voting Rights Announcements	2024-10-24	English
Felix Trial registration update 3 pages 182.8KB Capital/Financing Update	2024-10-23	English
Investor Webinar Invitation 2 pages 140.1KB Investor Presentation	2024-10-23	English
Extension of SPP offer 2 pages 225.2KB Capital/Financing Update	2024-10-21	English
Update - Proposed issue of securities - MEM 12 pages 38.1KB Capital/Financing Update	2024-10-21	English
Equine study commences with 12mth commercialisation expected 3 pages 193.4KB Capital/Financing Update	2024-10-17	English
Supplementary Prospectus disclosure update 1 page 1 Capital/Financing Update	2024-10-17	English
Notice of Annual General Meeting/Proxy Form 15 pages 571.4KB AGM Information	2024-10-10	English
Supplementary Prospectus 7 pages 199.1KB Capital/Financing Update	2024-10-07	English
Notice of General Meeting/Proxy Form 27 pages 457.6KB Proxy Solicitation & Information Statement	2024-09-24	English
Target Market Determination (SPP Offer) 4 pages 254.6KB Regulatory Filings	2024-09-24	English
Patent filed for novel antioxidant assay system, RoXsta 2 pages 203.2KB Regulatory Filings	2024-09-22	English
Update - Proposed issue of securities - MEM 12 pages 38.1KB Capital/Financing Update	2024-09-22	English
Prospectus 39 pages 523.1KB Capital/Financing Update	2024-09-19	English
Annual Financial Report for the year ended 30 June 2024 73 pages 2.5MB Annual Report FY 2024	2024-09-17	English
Short term loan facility 2 pages 211.5KB Capital/Financing Update	2024-09-16	English
Proposed issue of securities - MEM 6 pages 21.7KB Capital/Financing Update	2024-09-16	English
Positive initial study results - Felix equine application 2 pages 198.1KB Capital/Financing Update	2024-09-15	English
A$2 million capital raising 4 pages 318.6KB Capital/Financing Update	2024-09-11	English
Proposed issue of securities - MEM 12 pages 37.6KB Capital/Financing Update	2024-09-11	English
Reinstatement to Official Quotation 1 page 417.0KB Regulatory Filings	2024-09-11	English
Voluntary Suspension 2 pages 244.5KB Capital/Financing Update	2024-09-10	English
Trading Halt 2 pages 247.6KB Capital/Financing Update	2024-09-08	English
Response to ASX Query 5 pages 814.6KB Regulatory Filings	2024-09-05	English
Retraction of Cleansing Notice dated 29 August 2024 1 Regulatory Filings	2024-09-05	English
Equine fertility study positions Felix as leading technology 3 pages 258.4KB Regulatory Filings	2024-09-03	English
Notification of cessation of securities - MEM 4 pages 14.9KB Regulatory Filings	2024-09-01	English
Preliminary Final Report 22 pages 1.2MB Annual Report FY 2024	2024-08-29	English
Securities Trading Policy 9 pages 280.5KB Board/Management Information	2024-08-29	English
2024 Corporate Governance Statement and App4G 24 pages 667.1KB Governance Information	2024-08-29	English
Application for quotation of securities - MEM 6 pages 18.4KB Share Issue/Capital Change	2024-08-28	English
Notification regarding unquoted securities - MEM 6 pages 19.7KB Share Issue/Capital Change	2024-08-28	English
Cleansing Statement 1 page 176.9KB Capital/Financing Update	2024-08-28	English
Proposed issue of securities - MEM 6 pages 20.3KB Capital/Financing Update	2024-08-26	English
Notification of cessation of securities - MEM 4 pages 14.9KB Regulatory Filings	2024-07-31	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 602.9KB Interim / Quarterly Report Q4 2024	2024-07-30	English
$1M secured from major shareholder and R&D Tax Rebate loan 2 pages 254.1KB Capital/Financing Update	2024-07-28	English
Felix sales clinical trial and Oxidative Stress devel update 5 pages 375.8KB Capital/Financing Update	2024-07-23	English
Animal activity update - oxidative stress measurement system 2 pages 228.4KB Capital/Financing Update	2024-07-18	English
Dr David Ali appointed full-time Chief Executive Officer 2 pages 191.9KB Board/Management Information	2024-06-05	English
Details of Company Address 1 page 155.6KB Regulatory Filings	2024-06-05	English
Notification regarding unquoted securities - MEM 6 pages 18.6KB Share Issue/Capital Change	2024-06-02	English
Application for quotation of securities - MEM 6 pages 18.5KB Share Issue/Capital Change	2024-06-02	English
Notification regarding unquoted securities - MEM 5 pages 16.9KB Share Issue/Capital Change	2024-06-02	English
s708 cleansing statement 1 page 174.8KB Capital/Financing Update	2024-06-02	English
Industry experts to expedite animal breeding products 2 pages 235.7KB Board/Management Information	2024-05-29	English
Investor Presentation 51 pages 4.7MB Investor Presentation	2024-05-20	English
Investor webinar invitation 1 page 217.1KB Investor Presentation	2024-05-19	English
Felix Japanese trial provides sperm preparation benefits 2 pages 224.8KB Capital/Financing Update	2024-05-19	English
2024 Investor Presentation 45 pages 4.7MB Investor Presentation	2024-05-08	English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 479.7KB Interim / Quarterly Report Q3 2024	2024-04-28	English
Felix TM System Sales Orders Accelerate in Japan 3 pages 224.7KB Capital/Financing Update	2024-03-17	English
EGM update and advance of funds 1 page 186.1KB Capital/Financing Update	2024-03-17	English
Director Appointment - Michael Atkins 2 pages 205.2KB Board/Management Information	2024-03-13	English
Initial Director's Interest Notice MA 2 pages 205.4KB Director's Dealing	2024-03-13	English
Half Yearly Report and Accounts 23 pages 1.6MB Interim / Quarterly Report H1 2024	2024-02-25	English
s708A cleansing statement 1 page 174.4KB Capital/Financing Update	2024-02-19	English
Application for quotation of securities - MEM 6 pages 18.5KB Share Issue/Capital Change	2024-02-18	English
Notification regarding unquoted securities - MEM 7 pages 22.1KB Share Issue/Capital Change	2024-02-18	English
Notification regarding unquoted securities - MEM 6 pages 20.8KB Share Issue/Capital Change	2024-02-18	English
Results of General Meeting 1 page 158.7KB Declaration of Voting Results & Voting Rights Announcements	2024-02-14	English
AI-Port Update - Spring Field Trial Yields Positive Results 2 pages 247.1KB Regulatory Filings	2024-01-24	English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 445.3KB Interim / Quarterly Report Q2 2024	2024-01-24	English
Change of venue for General Meeting of shareholders 1 Regulatory Filings	2024-01-18	English
Appendix 2A rights issue entitlement 20 pages 514.2KB Regulatory Filings	2024-01-17	English
Appendix 3G rights issue entitlement options 18 pages 502.2KB Share Issue/Capital Change	2024-01-17	English
Rights issue entitlement offer completion 1 page 17 Capital/Financing Update	2024-01-17	English
Top 20 securityholders 2 pages 117.6KB Major Shareholding Notification	2024-01-17	English
Appendix 3B - Extension of Settlement Date 54 pages 1.2MB Capital/Financing Update	2024-01-16	English
Appendix 3B extension of settlement date 54 pages 1.1MB Capital/Financing Update	2024-01-15	English
Rights Issue Shortfall 1 page 176.2KB Capital/Financing Update	2024-01-11	English
Notice of General Meeting/Proxy Form 98 pages 1.8MB Proxy Solicitation & Information Statement	2024-01-09	English
Vitrolife distribution agreement expands into Canada and NZ 3 pages 210.6KB Capital/Financing Update	2024-01-01	English
Notification of cessation of securities - MEM 4 pages 23.9KB Share Issue/Capital Change	2024-01-01	English

Filings by year

2026 25 filings
2025 90 filings
2024 100 filings
2023 43 filings
2022 53 filings
2021 47 filings
2020 33 filings
2019 62 filings
2018 52 filings
2017 62 filings
2016 74 filings
2015 51 filings
2014 48 filings
2013 65 filings
2012 68 filings
2011 80 filings
2010 87 filings
2009 81 filings
2008 56 filings
2007 48 filings